Viewing data from:

DIHYDROERGOTAMINE MESYLATE

ANDA

DIHYDROERGOTAMINE MESYLATE | A212907 | CIPLA LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: MIGRANAL(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 2 NDCs

Highest NADAC/Unit

$50.12

per ml

Lowest NADAC/Unit

$30.15

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
69097050331DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY	$50.12	ML	Generic	—	2026-08-19
69097050327DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY	$30.15	ML	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain4 active DMFs2 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVDIHYDROERGOTAMINE MESYLATE

DMF 149442000

CURIA ITALY SRLDIHYDROERGOTAMINE MESYLATE USP/EP

DMF 224072009

OLON SPADIHYDROERGOTAMINE MESYLATE

DMF 304972016

OLON SPADIHYDROERGOTAMINE MESYLATE

DMF 330222018

BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGInactiveDIHYDROERGOTAMINE MESYLATE

DMF 102421993

LEK PHARMACEUTICALS DDInactiveDIHYDROERGOTAMINE MESYLATE

DMF 161942002

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jun 8, 2020	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 0.5MG/SPRAY

0 patents0 exclusivities▴

SPRAY, METERED;NASAL | Approved: May 20, 2020

No patent or exclusivity listings for this strength.